Literature DB >> 19552979

Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs.

Wilko F A R Verbakel1, Suresh Senan, Johan P Cuijpers, Ben J Slotman, Frank J Lagerwaard.   

Abstract

The delivery of high dose conventional stereotactic body radiotherapy (SBRT) for patients with stage I lung tumors generally takes 30-45min per fraction. The novel volumetric intensity-modulated arc therapy (RA) for planning and delivery enabled much faster treatment for three patients with different fractionation schemes. This reduces the risk of intrafraction motion and is more patient friendly. In addition, in comparison to the conventional plans using 10 static non-coplanar fields, RA plans achieved superior dose conformity around the PTV and reduced chest wall doses.

Entities:  

Mesh：

Year:  2009        PMID： 19552979     DOI： 10.1016/j.radonc.2009.05.020

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  48 in total

1.  Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Hui-Min Ting; Su-Hua Lo; Yu-Wen Wang; Chiu-Ching Tuan; Fu-Min Fang; Te-Jen Su
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

2.  Dosimetric effects of roll rotational setup errors on lung stereotactic ablative radiotherapy using volumetric modulated arc therapy.

Authors:  Jaegi Lee; Jung-In Kim; Sung-Joon Ye; Hak Jae Kim; Joel Carlson; Jong Min Park
Journal:  Br J Radiol       Date:  2015-09-15       Impact factor: 3.039

3.  Interplay effect modeling in stereotactic body radiotherapy treatment of liver cancer using volumetric modulated arc therapy.

Authors:  Deepak Thaper; Arun S Oinam; Rose Kamal; Gaganpreet Singh; Bhumika Handa; Vivek Kumar; Hanuman P Yadav
Journal:  Phys Eng Sci Med       Date:  2021-02-04

4.  Development of raster scanning IMRT using a robotic radiosurgery system.

Authors:  Hiroya Shiomi; Yuichi Akino; Iori Sumida; Norihisa Masai; Ryoong-Jin Oh; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

5.  Survey of stereotactic ablative body radiotherapy in the UK by the QA group on behalf of the UK SABR Consortium.

Authors:  G Distefano; A Baker; A J D Scott; G J Webster
Journal:  Br J Radiol       Date:  2014-03-13       Impact factor: 3.039

6.  Stereotactic body radiotherapy for stage I non-small cell lung cancer.

Authors:  Ben J Slotman
Journal:  J Radiosurg SBRT       Date:  2011

7.  Asymmetric margin setting at the cranial and caudal sides in respiratory gated and non-gated stereotactic body radiotherapy for lung cancer.

Authors:  Yoshihiro Ueda; Shingo Oohira; Masaru Isono; Masayoshi Miyazaki; Teruki Teshima
Journal:  Br J Radiol       Date:  2015-12-23       Impact factor: 3.039

8.  Volumetric modulated arc therapy for advanced pancreatic cancer.

Authors:  Wietse Eppinga; Frank Lagerwaard; Wilko Verbakel; Ben Slotman; Suresh Senan
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

9.  Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy.

Authors:  Marta Scorsetti; Piera Navarria; Fiorenza De Rose; AnnaMaria Ascolese; Elena Clerici; Ciro Franzese; Francesca Lobefalo; Giacomo Reggiori; Pietro Mancosu; Stefano Tomatis; Antonella Fogliata; Luca Cozzi
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-17       Impact factor: 4.553

10.  Dosimetry Comparison between Volumetric Modulated Arc Therapy with Rapid Arcand Fixed Field Dynamic IMRT for Local-Regionally Advanced Nasopharyngeal Carcinoma.

Authors:  Bao-Min Zheng; Xiao-Xia Dong; Hao Wu; Shu-Kui Han; Yan Sun
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.